Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT05130983
Brief Title: A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease

First Submitted : November 16, 2021
First Submitted that Met QC Criteria : November 16, 2021
First Posted : November 23, 2021

Last Update Submitted that Met QC Criteria : December 7, 2021
Last Update Posted : December 22, 2021